It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 1973.
1973 | Kanpur, Uttar Pradesh, India | ActiveBipra Pharmaceuticals Private Limited, a active private limited company, was established on 22 December 1973 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24231UP1973PTC003831. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Kalindi Dutt Shukla (Additional Director), Aishwarya Dutt Shukla (Managing Director), Anuruddh Singh (Director). Past directors included Ravindra Nath Chaudhary, Rajeev Mohan. It holds ₹0.50 M open charges and ₹3.21 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 111A/185 Ashok Nagar, Kanpur, Uttar Pradesh, 208012.
U24231UP1973PTC003831
003831
22 December 1973
₹0.50 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Bipra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalindi Dutt Shukla | Additional Director | 30 Sep 2024 | Current |
| Aishwarya Dutt Shukla | Managing Director | 07 Sep 2020 | Current |
| Anuruddh Singh | Director | 05 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2020 | Past |
| Pramod Abcsdd | Managing Director | 05 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bipra Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 20% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Bipra Pharmaceuticals had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹32,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 1993 | State Bank Of India Industrial Estate | ₹0.50 M | Open |
| 27 Feb 1991 | Uttar Pradesh Financial Corporation | ₹3.16 Cr | Satisfied |
| 16 Jun 1990 | Uttar Pradesh Financial Corporation | ₹0.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bipra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bipra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bipra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Bipra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Kalindi Dutt Shukla was appointed as a Additional Director was appointed as a Additional Director on 30 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Bipra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity A charge registered on 27 Feb 1991 via Charge ID 90278457 with Uttar Pradesh Financial Corporation was fully satisfied on 04 Nov 2022. was completed.
A charge registered on 16 Jun 1990 via Charge ID 90278421 with Uttar Pradesh Financial Corporation was fully satisfied on 04 Nov 2022. was recorded as a recent event.
Progress on Anuruddh Singh was appointed as a Director was appointed as a Director on 05 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
The CIN of Bipra Pharmaceuticals Private Limited is U24231UP1973PTC003831.
Bipra Pharmaceuticals Private Limited is headquartered at 111A/185 Ashok Nagar, Kanpur, Uttar Pradesh, 208012.
Bipra Pharmaceuticals Private Limited was incorporated on 22 December 1973.
The current directors of Bipra Pharmaceuticals Private Limited are
The primary industry of Bipra Pharmaceuticals Private Limited is Hospital And Medical Care.
Bipra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bipra Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Bipra Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX